Table 1 Baseline clinical characteristics
IMR ≤ 40 U (n = 28) | IMR > 40 U (n = 25) | p value | |
|---|---|---|---|
Male | 23 (82.1) | 23 (92.0) | 0.295 |
Age (years) | 56.2 ± 10.5 | 60.2 ± 10.2 | 0.168 |
Hypertension | 17 (60.7) | 17 (68.0) | 0.775 |
Diabetes mellitus | 7 (25.0) | 8 (32.0) | 0.761 |
Smoking | 21 (75.0) | 13 (52.0) | 0.095 |
Hyperlipemia | 4 (14.3) | 6 (24.0) | 0.488 |
Ischemic time (min) | 246 ± 180 | 293 ± 150 | 0.293 |
D–B (min) | 81.0 ± 24.2 | 74.6 ± 24.1 | 0.340 |
Admission BP SBP (mmHg) DBP (mmHg) | 130.4 ± 15.9 80.4 ± 16.5 | 126.6 ± 15.0 80.4 ± 11.0 | 0.377 0.986 |
Periprocedural medication | |||
Aspirin P2Y12 ACEI Statin β-blocker | 28 (100.0) 28 (100.0) 28 (100.0) 28 (100.0) 28 (100.0) | 25 (100.0) | – |
25 (100.0) | – | ||
25 (100.0) | – | ||
25 (100.0) | – | ||
25 (100.0) | – | ||
Hemoglobin (g/L) | 124.6 ± 7.7 | 125.6 ± 7.4 | 0.609 |
Blood glucose (mmol/L) | 6.5 ± 1.7 | 6.5 ± 2.2 | 0.637 |
T-CHO (mmol/L) | 5.4 ± 1.7 | 5.0 ± 1.6 | 0.321 |
LDL-C (mmol/L) | 2.7 ± 0.8 | 2.7 ± 0.8 | 0.586 |
HbA1c (%) | 5.7 ± 0.8 | 6.1 ± 1.4 | 0.214 |
BNP (pg/ml) | 218.6 ± 136.5 | 254.5 ± 220.1 | 0.542 |
IMR | 22.4 ± 6.6 | 43.6 ± 3.7 | < 0.001 |